Inventor
LYNCH CHRISTOPHER L
US21 patents
⚠️ This page may combine multiple inventors who share the name “LYNCH CHRISTOPHER L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
10 patentsUS7390799B2Jun 24, 2008
Apoptosis promoters
ABBOTT LAB331 citations98
US8354404B2Jan 15, 2013
Apoptosis promoters
ABBOTT LAB39 citations97
US7973161B2Jul 5, 2011
Apoptosis promoters
ABBOTT LAB70 citations97
US7767684B2Aug 3, 2010
Apoptosis promoters
ABBOTT LAB107 citations97
US7709467B2May 4, 2010
Apoptosis promoters
ABBOTT LAB50 citations97
US7642260B2Jan 5, 2010
Apoptosis promoters
ABBOTT LAB82 citations97
US7906505B2Mar 15, 2011
Apoptosis promoters
ABBOTT LAB18 citations92
US7872017B2Jan 18, 2011
Fused bicycloheterocycle substituted azabicyclic alkane derivatives
ABBOTT LAB31 citations92
US7741364B2Jun 22, 2010
Pyrrole derivatives and their methods of use
ABBOTT LAB23 citations89
US7777076B2Aug 17, 2010
Macrocyclic inhibitors of BCL proteins
ABBOTT LAB6 citations63
MERCK & CO INC
4 patentsUS7309721B2Dec 18, 2007
Aminoalkylphosphonates and related compounds as Edg receptor agonists
MERCK & CO INC37 citations91
US7479504B2Jan 20, 2009
Edg receptor agonists
MERCK & CO INC28 citations90
US7199142B2Apr 3, 2007
1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
MERCK & CO INC21 citations83
US7125887B2Oct 24, 2006
Pyrrolidine modulators of CCR5 chemokine receptor activity
MERCK & CO INC1 citations49